Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2019 Financial Results


You May Also Like

Sorrento Therapeutics, Inc. Chairman/CEO letter to stockholders

SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Dear Sorrento Stockholders, Since its inception ...

Evoke Pharma Completes Credit Facility Repayment

SOLANA BEACH, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK) (the ...